Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
17 participants
OBSERVATIONAL
2013-04-30
2014-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lung Sounds as Indicators of Severity and Recovery of Lung Disease
NCT02053870
Novel Markers of Disease Progression in Interstitial Lung Disease
NCT05760508
Digital Auscultation Test - IPF Data Collection
NCT03503188
Study of Lung Proteins in Patients With Pneumonia
NCT00077909
Dyspnea and Idiopathic Pulmonary Fibrosis
NCT04864990
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lung Sound Analyzer
Patient with pneumonia admitted to hospital will receive additional auscultation with lung sound analyzing stethoscope
Lung sound analyzer
Patients will be aucultated with lung sound analyzer. The auscultation will be done three times daily during the duration of the complete hospital stay.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lung sound analyzer
Patients will be aucultated with lung sound analyzer. The auscultation will be done three times daily during the duration of the complete hospital stay.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* hospitalisation at medical clinic I, university hospital Aachen
* age at least \> 18 years
* CRB-65 score \> 1
* CRP\> 60mg/l
* fever
* lung sounds audible by stethoscope
* legal capacity and being able to understand and to follow the instructions of the study staff
* being able to consent and being able to understand the importance and the consequence of the study
* not being accomondated in an institution
Exclusion Criteria
* artificial respiration or other means for supporting respiration
* allergic reaction because of skin contact with polymers
* pregnancy or breast feeding
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
RWTH Aachen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christian Cornelissen, MD
Role: PRINCIPAL_INVESTIGATOR
RWTH Aachen University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Univeristy Hospital Aachen
Aachen, North Rhine Westfalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12-116
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.